Progress in the Diagnosis and Treatment of COVID-19 in Children: A Review

References

• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Li M, Zhu D, Yang J, et al. Clinical treatment experience in severe and critical COVID-19. Mediators Inflamm. 2021;2021:9924542. doi:10.1155/2021/9924542
   PubMedGoogle Scholar
• Shen KL, Yang YH, Jiang RM, et al. Updated diagnosis, treatment and prevention of COVID-19 in children: experts’ consensus statement (condensed version of the second edition). World J Pediatr. 2020;16(3):232–239. doi:10.1007/s12519-020-00362-4
   PubMed Web of Science ®Google Scholar
• Sahi PK, Jhamb U, Dabas A. Pediatric coronavirus disease 2019: clinical features and management. Indian Pediatr. 2021;58(5):453–460. doi:10.1007/s13312-021-2216-4
   PubMed Web of Science ®Google Scholar
• Girona-Alarcon M, Bobillo-Perez S, Sole-Ribalta A, et al. The different manifestations of COVID-19 in adults and children: a cohort study in an intensive care unit. BMC Infect Dis. 2021;21(1):87. doi:10.1186/s12879-021-05786-5
   PubMed Web of Science ®Google Scholar
• Khera N, Santesmasses D, Kerepesi C, et al. COVID-19 mortality rate in children is U-shaped. Aging. 2021;13(16):19954–19962. doi:10.18632/aging.203442
   PubMedGoogle Scholar
• He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672–675. doi:10.1038/s41591-020-0869-5
   PubMed Web of Science ®Google Scholar
• Jing QL, Liu MJ, Zhang ZB, et al. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(10):1141–1150. doi:10.1016/S1473-3099(20)30471-0
   PubMed Web of Science ®Google Scholar
• Vermund SH, Pitzer VE. Asymptomatic transmission and the infection fatality risk for COVID-19: implications for school reopening. Clin Infect Dis. 2021;72(9):1493–1496. doi:10.1093/cid/ciaa855
   PubMed Web of Science ®Google Scholar
• Massalska MA, Gober HJ. How children are protected from COVID-19? A historical, clinical, and pathophysiological approach to address COVID-19 susceptibility. Front Immunol. 2021;12:646894. doi:10.3389/fimmu.2021.646894
   PubMed Web of Science ®Google Scholar
• Kortz TB, Connolly E, Cohen CL, et al. Diagnosis and acute management of COVID-19 and multisystem inflammatory syndrome in children. Pediatr Emerg Care. 2021;37(10):519–525. doi:10.1097/PEC.0000000000002538
   PubMed Web of Science ®Google Scholar
• Rowley AH. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nat Rev Immunol. 2020;20(8):453–454. doi:10.1038/s41577-020-0367-5
   PubMed Web of Science ®Google Scholar
• Haslak F, Barut K, Durak C, et al. Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children. Clin Rheumatol. 2021;40(10):4167–4178. doi:10.1007/s10067-021-05780-x
   PubMed Web of Science ®Google Scholar
• Noval Rivas M, Porritt RA, Cheng MH, et al. COVID-19-associated multisystem inflammatory syndrome in children (MIS-C): a novel disease that mimics toxic shock syndrome-The superantigen hypothesis. J Allergy Clin Immunol. 2021;147(1):57–59. doi:10.1016/j.jaci.2020.10.008
   PubMed Web of Science ®Google Scholar
• Mansourian M, Ghandi Y, Habibi D, et al. COVID-19 infection in children: a systematic review and meta-analysis of clinical features and laboratory findings. Arch Pediatr. 2021;28(3):242–248. doi:10.1016/j.arcped.2020.12.008
   PubMed Web of Science ®Google Scholar
• Cai J, Wang X, Zhao J, et al. Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection in children. Virol Sin. 2020;35(6):803–810. doi:10.1007/s12250-020-00312-4
   PubMed Web of Science ®Google Scholar
• Grudlewska-Buda K, Wiktorczyk-Kapischke N, Wałecka-Zacharska E, et al. SARS-CoV-2-morphology, transmission and diagnosis during pandemic, review with element of meta-analysis. J Clin Med. 2021;10(9):1962. doi:10.3390/jcm10091962
   PubMed Web of Science ®Google Scholar
• Stacevičienė I, Burokienė S, Steponavičienė A, et al. A cross-sectional study of screening for coronavirus disease 2019 (COVID-19) at the pediatric emergency department in Vilnius during the first wave of the pandemic. Eur J Pediatr. 2021;180(7):2137–2145. doi:10.1007/s00431-021-03999-z
   PubMed Web of Science ®Google Scholar
• Siebach MK, Piedimonte G, Ley SH. COVID-19 in childhood: transmission, clinical presentation, complications and risk factors. Pediatr Pulmonol. 2021;56(6):1342–1356. doi:10.1002/ppul.25344
   PubMed Web of Science ®Google Scholar
• Li X, Rong Y, Zhang P, et al. Differences in clinical features and laboratory results between adults and children with SARS-CoV-2 Infection. Biomed Res Int. 2020;2020:6342598. doi:10.1155/2020/6342598
   PubMed Web of Science ®Google Scholar
• Gaythorpe KAM, Bhatia S, Mangal T, et al. Children’s role in the COVID-19 pandemic: a systematic review of early surveillance data on susceptibility, severity, and transmissibility. Sci Rep. 2021;11(1):13903. doi:10.1038/s41598-021-92500-9
   PubMed Web of Science ®Google Scholar
• Zare-Zardini H, Soltaninejad H, Ferdosian F, et al. Coronavirus disease 2019 (COVID-19) in children: prevalence, diagnosis, clinical symptoms, and treatment. Int J Gen Med. 2020;13:477–482. doi:10.2147/IJGM.S262098
   PubMed Web of Science ®Google Scholar
• Alharbi M, Kazzaz YM, Hameed T, et al. SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia. J Infect Public Health. 2021;14(4):446–453. doi:10.1016/j.jiph.2020.12.034
   PubMed Web of Science ®Google Scholar
• Li X, Sun L, Li T. Updates in neonatal coronavirus disease 2019: what can we learn from detailed case reports?. Mol Med Rep. 2021;23(5). doi:10.3892/mmr.2021.11990
   Web of Science ®Google Scholar
• Gale C, Quigley MA, Placzek A, et al. Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance. Lancet Child Adolesc Health. 2021;5(2):113–121. doi:10.1016/S2352-4642(20)30342-4
   PubMedGoogle Scholar
• Kaufman DA, Puopolo KM. Infants born to mothers with COVID-19-making room for rooming-in. JAMA Pediatr. 2021;175(3):240–242. doi:10.1001/jamapediatrics.2020.5100
   PubMed Web of Science ®Google Scholar
• Kumar A, Singh R, Kaur J, et al. Wuhan to world: the COVID-19 pandemic. Front Cell Infect Microbiol. 2021;11:596201. doi:10.3389/fcimb.2021.596201
   PubMed Web of Science ®Google Scholar
• Kantar A, Mazza A, Bonanomi E, et al. COVID-19 and children with Down syndrome: is there any real reason to worry? Two case reports with severe course. BMC Pediatr. 2020;20(1):561. doi:10.1186/s12887-020-02471-5
   PubMed Web of Science ®Google Scholar
• Kurtz A, Grant K, Marano R, et al. Long-term effects of malnutrition on severity of COVID-19. Sci Rep. 2021;11(1):14974. doi:10.1038/s41598-021-94138-z
   PubMed Web of Science ®Google Scholar
• Kompaniyets L, Agathis NT, Nelson JM, et al. Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Netw Open. 2021;4(6):e2111182. doi:10.1001/jamanetworkopen.2021.11182
   PubMed Web of Science ®Google Scholar
• Schuster JE, de St Maurice A. COVID-19 in children-not just little adults. JAMA Netw Open. 2021;4(6):e2111441. doi:10.1001/jamanetworkopen.2021.11441
   PubMed Web of Science ®Google Scholar
• Rao SK, Kumar A, Prasad R, et al. Clinical profile and outcome of COVID-19 among immunocompromised children. Indian Pediatr. 2021;58(7):686–687. doi:10.1007/s13312-021-2267-6
   PubMed Web of Science ®Google Scholar
• Karaaslan A, Çetin C, Akın Y, et al. Coinfection in SARS-CoV-2 infected children patients. J Infect Dev Ctries. 2021;15(6):761–765. doi:10.3855/jidc.14314
   PubMed Web of Science ®Google Scholar
• Tasakis RN, Samaras G, Jamison A, et al. SARS-CoV-2 variant evolution in the United States: high accumulation of viral mutations over time likely through serial Founder Events and mutational bursts. PLoS One. 2021;16(7):e0255169. doi:10.1371/journal.pone.0255169
   PubMed Web of Science ®Google Scholar
• Aygün D, Önal P, Apaydın G, et al. Coronavirus infections in childhood and vaccine studies. Turk Arch Pediatr. 2021;56(1):10–14.
   PubMed Web of Science ®Google Scholar
• Felsenstein S, Hedrich CM. SARS-CoV-2 infections in children and young people. Clin Immunol. 2020;220:108588. doi:10.1016/j.clim.2020.108588
   PubMed Web of Science ®Google Scholar
• Gu H, Xie Z, Li T, et al. Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus. Sci Rep. 2016;6:19840. doi:10.1038/srep19840
   PubMed Web of Science ®Google Scholar
• Mohamed MS, Moulin TC, Schiöth HB. Sex differences in COVID-19: the role of androgens in disease severity and progression. Endocrine. 2021;71(1):3–8. doi:10.1007/s12020-020-02536-6
   PubMed Web of Science ®Google Scholar
• Wang K, Chen W, Zhang Z, et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 2020;5(1):283. doi:10.1038/s41392-020-00426-x
   PubMed Web of Science ®Google Scholar
• van Eijk LE, Binkhorst M, Bourgonje AR, et al. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. J Pathol. 2021;254:307–331.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155–162. doi:10.1097/BOR.0000000000000776
   PubMed Web of Science ®Google Scholar
• Tsai SF, Lu KY, Chuang HM, et al. Surviving the Rookie virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): the immunopathology of a SARS-CoV2 infection. Cell Transplant. 2021;30:963689721993769. doi:10.1177/0963689721993769
   PubMed Web of Science ®Google Scholar
• Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5(1):33. doi:10.1038/s41392-020-0148-4
   PubMed Web of Science ®Google Scholar
• Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):8. doi:10.1038/s41368-020-0074-x
   PubMed Web of Science ®Google Scholar
• Zheng H, Li H, Guo L, et al. Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: a nonhuman primate model of COVID-19 progression. PLoS Pathog. 2020;16(11):e1008949. doi:10.1371/journal.ppat.1008949
   PubMed Web of Science ®Google Scholar
• Nielsen SCA, Yang F, Jackson KJL, et al. Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2. Cell Host Microbe. 2020;28(4):516–525.e5. doi:10.1016/j.chom.2020.09.002
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhou X, Zhu C, et al. Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19. Front Mol Biosci. 2020;7:157. doi:10.3389/fmolb.2020.00157
   PubMed Web of Science ®Google Scholar
• Yang L, Xie X, Tu Z, et al. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct Target Ther. 2021;6(1):255.
   PubMed Web of Science ®Google Scholar
• Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718–724. doi:10.1126/science.abc6027
   PubMed Web of Science ®Google Scholar
• Bunyavanich S, Do A, Vicencio A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA. 2020;323(23):2427–2429. doi:10.1001/jama.2020.8707
   PubMed Web of Science ®Google Scholar
• Rawat M, Chandrasekharan P, Hicar MD, et al. COVID-19 in newborns and infants-low risk of severe disease: silver lining or dark cloud? Am J Perinatol. 2020;37(8):845–849. doi:10.1055/s-0040-1710512
   PubMed Web of Science ®Google Scholar
• Liu L, She J, Bai Y, et al. SARS-CoV-2 infection: differences in hematological parameters between adults and children. Int J Gen Med. 2021;14:3035–3047. doi:10.2147/IJGM.S313860
   PubMed Web of Science ®Google Scholar
• Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771–1778. doi:10.1016/S0140-6736(20)31103-X
   PubMed Web of Science ®Google Scholar
• Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334–346. doi:10.1056/NEJMoa2021680
   PubMed Web of Science ®Google Scholar
• Takia L, Angurana SK, Nallasamy K, et al. Updated management protocol for multisystem inflammatory syndrome in children (MIS-C). J Trop Pediatr. 2021;67(3). doi:10.1093/tropej/fmab071
   PubMed Web of Science ®Google Scholar
• Diorio C, Henrickson SE, Vella LA, et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest. 2020;130(11):5967–5975. doi:10.1172/JCI140970
   PubMed Web of Science ®Google Scholar
• McMurray JC, May JW, Cunningham MW, et al. Multisystem inflammatory syndrome in children (MIS-C), a post-viral myocarditis and systemic vasculitis-a critical review of its pathogenesis and treatment. Front Pediatr. 2020;8:626182. doi:10.3389/fped.2020.626182
   PubMed Web of Science ®Google Scholar
• Malviya A, Mishra A. Childhood multisystem inflammatory syndrome: an emerging disease with prominent cardiovascular involvement-a scoping review. SN Compr Clin Med. 2021;348–59.
   PubMedGoogle Scholar
• Porritt RA, Binek A, Paschold L, et al. The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. J Clin Invest. 2021;131(20). doi:10.1172/JCI151520
   Web of Science ®Google Scholar
• Consiglio CR, Cotugno N, Sardh F, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183(4):968–981.e7. doi:10.1016/j.cell.2020.09.016
   PubMed Web of Science ®Google Scholar
• Lee PY, Day-Lewis M, Henderson LA, et al. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020;130(11):5942–5950. doi:10.1172/JCI141113
   PubMed Web of Science ®Google Scholar
• Lazarevic I, Pravica V, Miljanovic D, et al. Immune evasion of SARS-CoV-2 emerging variants: what have we learnt so far? Viruses. 2021;13(7):1192. doi:10.3390/v13071192
   PubMed Web of Science ®Google Scholar
• McCormick KD, Jacobs JL, Mellors JW. The emerging plasticity of SARS-CoV-2. Science. 2021;371(6536):1306–1308. doi:10.1126/science.abg4493
   PubMed Web of Science ®Google Scholar
• Koyama T, Platt D, Parida L. Variant analysis of SARS-CoV-2 genomes. Bull World Health Organ. 2020;98(7):495–504. doi:10.2471/BLT.20.253591
   PubMed Web of Science ®Google Scholar
• Singh J, Samal J, Kumar V, et al. Structure-function analyses of new SARS-CoV-2 variants B.1.1.7, B.1.351 and B.1.1.28.1: clinical, diagnostic, therapeutic and public health implications. Viruses. 2021;13(3):439. doi:10.3390/v13030439
   PubMed Web of Science ®Google Scholar
• Plante JA, Liu Y, Liu J, et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021;592(7852):116–121. doi:10.1038/s41586-020-2895-3
   PubMed Web of Science ®Google Scholar
• Herlihy R, Bamberg W, Burakoff A, et al. Rapid increase in circulation of the SARS-CoV-2 B.1.617.2 (Delta) variant - Mesa County, Colorado, April-June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(32):1084–1087. doi:10.15585/mmwr.mm7032e2
   PubMed Web of Science ®Google Scholar
• Mallapaty S. COVID vaccines slash viral spread - but Delta is an unknown. Nature. 2021;596(7870):17–18. doi:10.1038/d41586-021-02054-z
   PubMed Web of Science ®Google Scholar
• Baraniuk C. Covid-19: how effective are vaccines against the delta variant? BMJ. 2021;374:n1960. doi:10.1136/bmj.n1960
   PubMed Web of Science ®Google Scholar
• Ledford H. Should children get COVID vaccines? What the science says. Nature. 2021;595(7869):638–639. doi:10.1038/d41586-021-01898-9
   PubMed Web of Science ®Google Scholar
• Irfan O, Li J, Tang K, et al. Risk of infection and transmission of SARS-CoV-2 among children and adolescents in households communities and educational settings: a systematic review and meta-analysis. J Glob Health. 2021;11:05013.
   PubMed Web of Science ®Google Scholar
• Kornitzer J, Johnson J, Yang M, et al. A systematic review of characteristics associated with COVID-19 in children with typical presentation and with multisystem inflammatory syndrome. Int J Environ Res Public Health. 2021;18(16):8269. doi:10.3390/ijerph18168269
   PubMed Web of Science ®Google Scholar
• Göktuğ A, Güngör A, Öz FN, et al. Evaluation of epidemiological, demographic, clinical characteristics and laboratory findings of COVID-19 in the pediatric emergency department. J Trop Pediatr. 2021;67(4). doi:10.1093/tropej/fmab066
   PubMed Web of Science ®Google Scholar
• Belsky JA, Tullius BP, Lamb MG, et al. COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients. J Infect. 2021;82(3):329–338. doi:10.1016/j.jinf.2021.01.022
   PubMed Web of Science ®Google Scholar
• Connelly JA, Chong H, Esbenshade AJ, et al. Impact of COVID-19 on pediatric immunocompromised patients. Pediatr Clin North Am. 2021;68(5):1029–1054. doi:10.1016/j.pcl.2021.05.007
   PubMed Web of Science ®Google Scholar
• Boronat S. Neurologic care of COVID-19 in children. Front Neurol. 2020;11:613832. doi:10.3389/fneur.2020.613832
   PubMed Web of Science ®Google Scholar
• Raj SL, Vasanthi T, Baineni R, et al. Neurological manifestations of COVID-19 in children. Indian Pediatr. 2020;57(12):1185–1186. doi:10.1007/s13312-020-2079-0
   PubMed Web of Science ®Google Scholar
• Hoseinyazdi M, Esmaeilian S, Jahankhah R, et al. Clinical, laboratory, and chest CT features of severe versus non-severe pediatric patients with COVID-19 infection among different age groups. BMC Infect Dis. 2021;21(1):560. doi:10.1186/s12879-021-06283-5
   PubMed Web of Science ®Google Scholar
• Bustos BR, Jaramillo-Bustamante JC, Vasquez-Hoyos P, et al. Pediatric inflammatory multisystem syndrome associated with SARS-CoV-2: a case series quantitative systematic review. Pediatr Emerg Care. 2021;37(1):44–47. doi:10.1097/PEC.0000000000002306
   PubMed Web of Science ®Google Scholar
• Lim CC, Saniasiaya J, Kulasegarah J. Croup and COVID-19 in a child: a case report and literature review. BMJ Case Rep. 2021;14(9):e244769. doi:10.1136/bcr-2021-244769
   PubMedGoogle Scholar
• Chou J, Platt CD, Habiballah S, et al. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). J Allergy Clin Immunol. 2021;148(3):732–738.e1. doi:10.1016/j.jaci.2021.06.024
   PubMed Web of Science ®Google Scholar
• Cui X, Zhang T, Zheng J, et al. Children with coronavirus disease 2019: a review of demographic, clinical, laboratory, and imaging features in pediatric patients. J Med Virol. 2020;92(9):1501–1510. doi:10.1002/jmv.26023
   PubMed Web of Science ®Google Scholar
• Erat T, Güler Ş. Use of radiological tests in COVID-19 positive child cases: is chest computed tomography necessary? Int J Clin Pract. 2021;e14259.
   PubMed Web of Science ®Google Scholar
• Foust AM, McAdam AJ, Chu WC, et al. Practical guide for pediatric pulmonologists on imaging management of pediatric patients with COVID-19. Pediatr Pulmonol. 2020;55(9):2213–2224. doi:10.1002/ppul.24870
   PubMed Web of Science ®Google Scholar
• Islam N, Ebrahimzadeh S, Salameh JP, et al. Thoracic imaging tests for the diagnosis of COVID-19. Cochrane Database Syst Rev. 2021;3:Cd013639.
   PubMed Web of Science ®Google Scholar
• Gregori G, Sacchetti R. Lung ultrasound in outpatient approach to children with suspected COVID 19. Ital J Pediatr. 2020;46(1):171. doi:10.1186/s13052-020-00938-w
   PubMed Web of Science ®Google Scholar
• Volpicelli G, Gargani L, Perlini S, et al. Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study. Intensive Care Med. 2021;47(4):444–454. doi:10.1007/s00134-021-06373-7
   PubMed Web of Science ®Google Scholar
• Musolino AM, Boccuzzi E, Supino MC, et al. Point-of-care lung ultrasound in the diagnosis and monitoring of paediatric patients with spontaneous pneumothorax in SARS-CoV-2 infection. J Paediatr Child Health. 2021;57(5):604–606. doi:10.1111/jpc.15410
   PubMed Web of Science ®Google Scholar
• Lazzerini M, Sforzi I, Trapani S, et al. Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020. Euro Surveill. 2021;26(14). doi:10.2807/1560-7917.ES.2021.26.14.2001248
   PubMedGoogle Scholar
• Qi K, Zeng W, Ye M, et al. Clinical, laboratory, and imaging features of pediatric COVID-19: a systematic review and meta-analysis. Medicine. 2021;100(15):e25230. doi:10.1097/MD.0000000000025230
   PubMed Web of Science ®Google Scholar
• Chiotos K, Hayes M, Kimberlin DW, et al. Multicenter interim guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2. J Pediatric Infect Dis Soc. 2021;10(1):34–48. doi:10.1093/jpids/piaa115
   PubMed Web of Science ®Google Scholar
• Galindo R, Chow H, Rongkavilit C. COVID-19 in children: clinical manifestations and pharmacologic interventions including vaccine trials. Pediatr Clin North Am. 2021;68(5):961–976. doi:10.1016/j.pcl.2021.05.004
   PubMed Web of Science ®Google Scholar
• Dolinger MT, Person H, Smith R, et al. Pediatric Crohn disease and multisystem inflammatory syndrome in children (MIS-C) and COVID-19 treated with infliximab. J Pediatr Gastroenterol Nutr. 2020;71(2):153–155. doi:10.1097/MPG.0000000000002809
   PubMed Web of Science ®Google Scholar
• Lee J, Lee J, Kim HJ, et al. TMPRSS2 and RNA-dependent RNA polymerase are effective targets of therapeutic intervention for treatment of COVID-19 caused by SARS-CoV-2 variants (B.1.1.7 and B.1.351). Microbiol Spectr. 2021;e0047221.
   PubMed Web of Science ®Google Scholar
• Xia S, Lan Q, Zhu Y, et al. Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation. Signal Transduct Target Ther. 2021;6(1):288. doi:10.1038/s41392-021-00712-2
   PubMed Web of Science ®Google Scholar
• Ren JL, Zhang AH, Wang XJ. Traditional Chinese medicine for COVID-19 treatment. Pharmacol Res. 2020;155:104743. doi:10.1016/j.phrs.2020.104743
   PubMed Web of Science ®Google Scholar
• Zhao Z, Li Y, Zhou L, et al. Prevention and treatment of COVID-19 using traditional Chinese medicine: a review. Phytomedicine. 2021;85:153308. doi:10.1016/j.phymed.2020.153308
   PubMed Web of Science ®Google Scholar
• Ren W, Liang P, Ma Y, et al. Research progress of traditional Chinese medicine against COVID-19. Biomed Pharmacother. 2021;137:111310. doi:10.1016/j.biopha.2021.111310
   PubMed Web of Science ®Google Scholar
• Wang WY, Xie Y, Zhou H, et al. Contribution of traditional Chinese medicine to the treatment of COVID-19. Phytomedicine. 2021;85:153279.
   PubMed Web of Science ®Google Scholar
• Li Y, Bi L, Li Y, et al. The effectiveness and safety of traditional Chinese medicine for the treatment of children with COVID-19. Medicine. 2020;99(30):e21247. doi:10.1097/MD.0000000000021247
   PubMed Web of Science ®Google Scholar
• Cerullo G, Negro M, Parimbelli M, et al. The long history of vitamin C: from prevention of the common cold to potential aid in the treatment of COVID-19. Front Immunol. 2020;11:574029. doi:10.3389/fimmu.2020.574029
   PubMed Web of Science ®Google Scholar
• Panfili FM, Roversi M, D’Argenio P, et al. Possible role of vitamin D in Covid-19 infection in pediatric population. J Endocrinol Invest. 2021;44(1):27–35. doi:10.1007/s40618-020-01327-0
   PubMed Web of Science ®Google Scholar
• Jung LS, Gund TM, Narayan M. Comparison of binding site of remdesivir and its metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 virus and alternative potential drugs for COVID-19 treatment. Protein J. 2020;39(6):619–630. doi:10.1007/s10930-020-09942-9
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang Y, Chen X, et al. Evaluating the efficacy and safety of bromhexine hydrochloride tablets in treating pediatric COVID-19: a protocol for meta-analysis and systematic review. Medicine. 2020;99(37):e22114. doi:10.1097/MD.0000000000022114
   PubMed Web of Science ®Google Scholar
• Ensinck G, Gregorio G, Flores RM, et al. [Consensus on treatment of multisystemic inflammatory syndrome associated with COVID-19]. Arch Argent Pediatr. 2021;119(4):S198–S211. Spanish.
   PubMedGoogle Scholar
• Dove ML, Jaggi P, Kelleman M, et al. Multisystem inflammatory syndrome in children: survey of protocols for early hospital evaluation and management. J Pediatr. 2021;229:33–40. doi:10.1016/j.jpeds.2020.10.026
   PubMed Web of Science ®Google Scholar
• Belhadjer Z, Méot M, Bajolle F, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142(5):429–436. doi:10.1161/CIRCULATIONAHA.120.048360
   PubMed Web of Science ®Google Scholar
• Jonat B, Gorelik M, Boneparth A, et al. Multisystem inflammatory syndrome in children associated with coronavirus disease 2019 in a children’s hospital in New York City: patient characteristics and an institutional protocol for evaluation, management, and follow-up. Pediatr Crit Care Med. 2021;22(3):e178–e191. doi:10.1097/PCC.0000000000002598
   PubMed Web of Science ®Google Scholar
• Ghanei M, Solaymani-Dodaran M, Qazvini A, et al. The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial. Respir Res. 2021;22(1):245. doi:10.1186/s12931-021-01833-6
   PubMed Web of Science ®Google Scholar
• Jain MK, Sahu SK, Behera JR, et al. Multisystem inflammatory syndrome in children associated with COVID 19 treated with oral steroid. Indian J Pediatr. 2021;88(1):106. doi:10.1007/s12098-020-03497-4
   PubMed Web of Science ®Google Scholar
• Son MBF, Murray N, Friedman K, et al. Multisystem inflammatory syndrome in children - initial therapy and outcomes. N Engl J Med. 2021;385(1):23–34. doi:10.1056/NEJMoa2102605
   PubMed Web of Science ®Google Scholar
• Belhadjer Z, Auriau J, Méot M, et al. Addition of corticosteroids to immunoglobulins is associated with recovery of cardiac function in multi-inflammatory syndrome in children. Circulation. 2020;142(23):2282–2284. doi:10.1161/CIRCULATIONAHA.120.050147
   PubMed Web of Science ®Google Scholar
• Khiali S, Entezari-Maleki T. Therapeutic application of corticosteroids in COVID-19: a focus on optimum dose and duration of therapy. J Clin Pharmacol. 2021;61(9):1145–1148. doi:10.1002/jcph.1929
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Guidelines, in COVID-19 rapid guideline: children and young people who are immunocompromised. National Institute for Health and Care Excellence (NICE); 2020.
   Google Scholar
• El Dannan H, Al Hassani M, Ramsi M. Clinical course of COVID-19 among immunocompromised children: a clinical case series. BMJ Case Rep. 2020;13(10):e237804. doi:10.1136/bcr-2020-237804
   PubMedGoogle Scholar
• Fishman JA, Grossi PA. Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve. Am J Transplant. 2020;20(7):1765–1767. doi:10.1111/ajt.15890
   PubMed Web of Science ®Google Scholar
• Saeed B. Impact of COVID-19 pandemic on management of pediatric kidney transplant recipients. Exp Clin Transplant. 2021;19(9):894–898. doi:10.6002/ect.2021.0275
   PubMed Web of Science ®Google Scholar
• Bai H, Ji Y, Wang J, et al. Efficacy of human coronavirus immune convalescent plasma for the treatment of Corona virus disease −19 disease in hospitalized children: a protocol for systematic review and meta analysis. Medicine. 2020;99(45):e22017. doi:10.1097/MD.0000000000022017
   PubMed Web of Science ®Google Scholar
• Joyner MJ, Klompas AM, Klassen SA, et al. In reply-how safe is COVID-19 convalescent plasma? Mayo Clin Proc. 2021;96(8):2281–2282. doi:10.1016/j.mayocp.2021.06.010
   PubMed Web of Science ®Google Scholar
• Tezer H, Bedir Demirdağ T. Novel coronavirus disease (COVID-19) in children. Turk J Med Sci. 2020;50(Si–1):592–603. doi:10.3906/sag-2004-174
   PubMed Web of Science ®Google Scholar